Prognostic Value of ERBB4 Expression in Patients With Triple Negative Breast Cancer

BMC Cancer - United Kingdom
doi 10.1186/s12885-016-2195-3
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Prognostic Value of Kallikrein-Related Peptidase 12 (KLK12) mRNA Expression in Triple-Negative Breast Cancer Patients

Molecular Medicine
Molecular MedicineGeneticsMolecular Biology
2020English

Neutrophil:Lymphocyte Ratios Have Prognostic Value in Triple-Negative Breast Cancer

Journal of Nihon University Medical Association
2017English

Prognostic Value of Ki-67 in Patients With Resected Triple-Negative Breast Cancer: A Meta-Analysis

Frontiers in Oncology
Cancer ResearchOncology
2019English

Prognostic Role of Family History in Patients With Triple Negative Breast Cancer

Turk Onkoloji Dergisi
Oncology
2020English

New Insights Into the Prognostic Value of Ki-67 Labeling Index in Patients With Triple-Negative Breast Cancer

Oncotarget
Oncology
2016English

Prognostic Value of Tumor-Infiltrating Lymphocytes in Patients With Triple-Negative Breast Cancer: A Systematic Review and Meta-Analysis

BMC Cancer
Cancer ResearchOncologyGenetics
2020English

The Prognostic Value of BRCA1 Promoter Methylation in Early Stage Triple Negative Breast Cancer

journal of Cancer Therapeutics and Research
2014English

Exploring Specific Prognostic Biomarkers in Triple-Negative Breast Cancer

Cell Death and Disease
Molecular NeuroscienceImmunologyCell BiologyCancer ResearchCellularMedicine
2019English

Prognostic Factors for Triple-Negative Breast Cancer Patients Receiving Preoperative Systemic Chemotherapy

Clinical Breast Cancer
Cancer ResearchOncology
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy